Cardiac Biomarkers Market to Reach USD 26.33 billion with CAGR of 11.2% by 2027; Approval for High-Sensitivity Troponin I Assays (TnIH) by FDA to Spur Opportunities, states Fortune Business Insights™ Pune, Oct. 05, 2020 (GLOBE NEWSWIRE) -- The global cardiac biomarkers market size is expected to reach USD 26.33 billion by 2027, exhibiting a CAGR of 11.2% during the forecast period. The growing...